🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMASH / Liver DiseaseSurvodutide MASH Phase 2b — 6 month update Page 3

Survodutide MASH Phase 2b — 6 month update

fiona_VT Sun, Dec 29, 2024 at 7:41 AM 16 replies 1,805 viewsPage 3 of 4
laura_annarbor
Member
189
890
Dec 2024
Ann Arbor, MI
Dec 29, 2024 at 11:56 AM#11
PharmacoVig_BOS said:
Survodutide MASH Phase 2b 6 month is not that straightforward in my experience

This is exactly right. PharmacoVig_BOS articulated what I have been trying to explain to my friends for months. The Survodutide MASH Phase 2b aspect is what made the difference for me.

2 16labquiet_amy, emily_PDX
Reply Quote Save Share Report
KristenIndy
Member
623
2,678
May 2024
Indianapolis, IN
Dec 29, 2024 at 12:13 PM#12

Reading this thread on Survodutide MASH Phase 2b hits close to home. Dad of 2 checking in — I started at 261 lbs and felt like I would tried everything.

7 months on tirz and I am a different person. Not just the 36 lbs lost — my energy, my mood, my relationship with food. All transformed.

If you are on the fence about Survodutide MASH — take the leap. It was the best health decision I have ever made. ❤️

45 10amsterdam_pete, LondonLisa, mike_nyc and 42 others
Reply Quote Save Share Report
Dr.EndoEP
Member
267
1,234
Oct 2024
El Paso, TX
Dec 29, 2024 at 12:30 PM#13

LibrarianMeg — that is really helpful context on Survodutide MASH Phase 2b. Follow-up question: how long did you wait before increasing your dose?

I am in a similar situation (week 4) and trying to set realistic expectations.

37 16FranDenver, Dr.BariatricHTX, LindaRN_retired and 34 others
Reply Quote Save Share Report
Dr.PainCLE
Senior Member
1,234
6,234
Mar 2024
Cleveland, OH
Dec 29, 2024 at 12:47 PM#14

To answer KristenIndy's question specifically:

From a clinical standpoint, Survodutide MASH Phase 2b 6 is a reasonable concern that deserves a thorough answer.

The short answer: the evidence supports this approach for most patients.

The longer answer involves reviewing the specific clinical trial data relevant to your question, which I am happy to elaborate on if helpful.

44 3bbq_ray_KC, oliver_london, tane_welly and 41 others
Reply Quote Save Share Report
MikeFit_NJ
Senior Member
1,567
6,543
Apr 2024
New Jersey
Dec 29, 2024 at 1:04 PM#15

Bookmarked 📌 The Survodutide MASH info in this thread is essential. Coming back to this for sure.

18 7Dr.EndoIndy, tom_AK, josh_phd_bmore and 15 others
Reply Quote Save Share Report

Similar Threads

Survodutide MASH Phase 2b — histological improvement data9 replies
Semaglutide and MASH — liver fat reduction quantification13 replies
Non-invasive MASH biomarkers — FibroScan, ELF, FIB-4 on GLP-110 replies
ALT normalization rates on GLP-1 — pooled trial data20 replies
GLP-1 hepatoprotection — direct vs indirect mechanisms16 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register